The largest database of trusted experimental protocols

Ca 7000 system

Manufactured by Sysmex
Sourced in Japan

The Sysmex CA 7000 system is a fully automated coagulation analyzer designed for clinical laboratory settings. It is capable of performing a wide range of coagulation and hemostasis tests, providing accurate and reliable results. The core function of the Sysmex CA 7000 system is to analyze coagulation parameters in patient samples.

Automatically generated - may contain errors

13 protocols using ca 7000 system

1

Automated Coagulation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assays were performed for each sample using an automatic coagulative instrument (Sysmex CA-7000 System) according to the instructions provided by the biological reagent provider (Siemens Healthcare Diagnostics Products Gmbh).
Fresh whole blood (50 ml), collected in sodium citrate coagulation test tubes, was donated by the first author of this paper, which was approved by the ethics committee of Puai Hospital. After centrifugation (3000 rpm, 8 min), the supernatants (270 μL) were divided into containers. Compounds 18 were diluted for use with normal saline (with 1% DMSO) at 1 mg/ml. Then, all of the isolates (30 μL) were added into the plasma sequentially. After incubation in a 37 °C thermostatic water bath for 10 minutes, all of the samples were analysed with the automatic coagulative instrument, which had been supplied with activated partial Thromborel S, Throbin, Dade Actin Activated Cephaloplastin Reagent (Siemens Healthcare Diagnostics Products Gmbh) and calcium-chloride solutions. All of the tests were performed in an automated environment.
+ Open protocol
+ Expand
2

Retrospective Analysis of Hepatic Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The laboratory data of all patients were reviewed retrospectively and included 1) biochemical tests reflecting hepatocytic damage: serum alanine transaminase (ALT), aspartate transaminase (AST), albumin (ALB), and total bilirubin, all assayed by colorimetric method (MODULAR EVO; Hoffmann-La Roche Ltd, Basel, Switzerland); 2) international standardized ratio for prothrombin time, determined according to the manufacturer’s instructions (CA-7000 System; Sysmex, Kobe, Japan); 3) HBV markers: HBV antigens (HBeAg) and antibodies (HBeAb), detected by commercially available enzyme immunoassays (Alisei Quality System; RADIM, Rome, Italy); and 4) HBV DNA, determined by fluorescent quantifying polymerase chain reaction with a low detection limit of 103 copies/mL (LightCycler 480; Hoffmann-La Roche Ltd).
+ Open protocol
+ Expand
3

Liver Disease Severity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each patient, demographic information and laboratory data were collected on admission. Laboratory parameters, including alanine aminotransferase, aspartate aminotransferase, total protein, albumin, creatinine, total bilirubin, INR, platelet count, hemoglobin, and blood urea nitrogen, were collected. Biochemical analyses were conducted using a Hitachi 7600 Clinical Analyzer (Hitachi, Tokyo, Japan), Sysmex CA-7000 System (Sysmex, Kobe, Japan), and Sysmex XE-2100 Auto-Analyzer (Sysmex, Kobe, Japan) using standard methods. PTAR was calculated as INR divided by albumin (g/dL). Hepatic disease severity was evaluated by the Model for End-Stage Liver Disease (MELD) score as previously described [8 (link)].
+ Open protocol
+ Expand
4

Cardiac Biomarker Measurement Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
D-dimer, TnI, N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP) were measured as cardiac biomarkers. D-dimer was measured with immunoturbidimetric assay using CA-7000 system (Sysmex, Kobe, Japan), and the reference value is < 0.5 mg/L. TnI was measured using electrochemiluminescence sandwich immunoassay method using Dimension RxL-Max (Siemens), and the reference value is < 0.05 ng/mL. NT-proBNP was measured using an electrochemiluminescence sandwich immunoassay method for NT-proBNP with an Elecsys 2010 analyzer (Roche Diagnostics, Mannheim, Germany). The analytic range of the NT-proBNP assay extends from 5 to 35,000 pg/mL. The reference value varies according to age and gender, and < 88 pg/mL for men and < 153 pg/mL for women in our institution. High-sensitivity C-reactive protein (hsCRP) was measured by the immunoturbidimetric CRP-Latex (II) assay using an Olympus 5431 autoanalyzer (Olympus America Inc., Center Valley, PA, USA) with reference range of < 0.5 mg/dL.
+ Open protocol
+ Expand
5

Comprehensive Blood Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A peripheral venous blood sample (6 mL) was collected from each
patient within the first 24 hours after admission to the ER. Blood
samples were used to analyze the hematological index and biochemical values.
Laboratory parameters measured included: white blood cells (WBC), platelets,
hemoglobin, red blood cell distribution width (RDW), neutrophil-lymphocyte
ratio (NLR), prothrombin time, total protein, albumin, alanine aminotransferase
(ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine
kinase (CK), creatinine, potassium, pH, PaCO2, and PaO2.
All biochemical analyses were conducted using a Hitachi 7600 Clinical Analyzer
(Hitachi, Tokyo, Japan), Sysmex CA-7000 System (Sysmex, Kobe, Japan), and
Sysmex XE-2100 Automated Analyzer (Sysmex) using standard methods.
+ Open protocol
+ Expand
6

Plasma D-dimer and Serum NSE Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood was collected from an antecubital vein into vacutainer tubes containing anticoagulant citrate buffer (1:9, buffer:blood; 3 mL of blood) and clotting agent (3.5 mL of blood), respectively, within 1 week prior to chemotherapy or radiotherapy. Plasma (for D-dimer assay) was obtained by centrifugation at 400 × g for 25 minutes. D-dimer levels were determined by immunoturbidimetric assay (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany) using a SYSMEX CA-7000 system (Sysmex Corp., Kobe, Japan). The cut-off value for plasma D-dimer levels used by the hospital laboratory was 0.55 mg/L fibrinogen equivalent units (FEU), based on the manufacturer’s recommendations. Serum (for neuron-specific enolase [NSE] assay) was obtained by centrifugation at 2860 × g for 15 minutes. Serum NSE levels were measured within 7 days before chemotherapy using a solid-phase radioimmunoassay method (SRL Inc., Tokyo, Japan). The cut-off value for plasma NSE levels was 16.3 ng/mL, based on the manufacturer’s recommendations.
+ Open protocol
+ Expand
7

Serum HMGB1 Levels in ER Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each patient provided a peripheral venous blood sample (5 mL) during the first 24 hours after admission to the ER. Sera were isolated, frozen, and stored at −80 °C until use. Serum HMGB1 levels were measured using an enzyme-linked immunosorbent assay kit according to the manufacturer’s instructions (Yanhui Biotech, Shanghai, China).
Baseline hematological and laboratory parameters, including white blood cell (WBC), neutrophil, lymphocyte, and platelet counts, hemoglobin, prothrombin time, total bilirubin, albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, serum amylase, troponin I (cTnI), pH, partial pressure of carbon dioxide (PaCO2), and partial pressure of oxygen (PaO2) were measured using a Hitachi 7600 Clinical Analyzer (Hitachi, Tokyo, Japan), Sysmex CA-7000 System (Sysmex, Kobe, Japan), and Sysmex XE-5000 (Sysmex)8 (link), according to standard protocols.
+ Open protocol
+ Expand
8

Pretreatment Plasma D-dimer and Albumin Levels in ESCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
As a part of clinical routine examinations, pretreatment plasma D-dimer levels, serum albumin levels, and CRP levels were measured 24 h to 1 week before surgery. Plasma D-dimer values were analyzed by a latex-enhanced immunoturbidimetric assay and a Sysmex CA 7000 system (Sysmex Corporation, Japan) according to the manufacturer’s instructions. Serum albumin levels and CRP levels were measured by using a Hitachi 7600-020 automatic biochemical analyzer (Hitachi, Japan). The optimal cutoff values of D-dimer and albumin in our study were verified using Youden’s index (YI) from the receiver operating characteristic (ROC) curve for ESCC prediction. The survival status was inserted into the YI to define the cutoff value as described by Huang et al. [22 (link)] and Liu et al. [23 (link)]. A high level of preoperative plasma D-dimer was defined as ≥0.5 μg/mL, and a low level of preoperative serum albumin was defined as <43.8 g/L.
+ Open protocol
+ Expand
9

Multicenter Coagulation Assay Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study was carried out in two laboratories, including the First Affiliated Hospital of Zhejiang University (Center 1) and The First People's Hospital of Hangzhou (Center 2). Both Centers, 1 and 2, used the same blood collection system (Becton Dickinson, Franklin Lakes, USA), Sysmex CA7000 system (Sysmex, Kobe, Japan), Siemens reagents (Siemens, Marburg, Germany), and International Sensitivity Index (ISI, ISI = 0.99).
+ Open protocol
+ Expand
10

Comprehensive Biomarker Assessment in Hospitalized Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
When the patients were admitted to hospital, venous blood was collected into the procoagulant tube and the EDTA-K2 anticoagulant tube. Serum was separated from the procoagulant tube and stored in the refrigerator at − 80 °C. A Siemens Advia 2400 automatic biochemical analyser (Siemens, Erlangen, Germany) and its supporting reagents were used to determine Lp(a), ApoB, ApoA-Ι, total cholesterol (TC), triglycerides (TG), TP (total protein), ALB (albumin), urea, Cr (creatinine), UA (uric acid), eGFR, Glu (glucose), HDL-C, LDL-C, sdLDL and hs-CRP (high-sensitivity C-reactive protein). Among them, a microparticle-enhanced transmission immunoassay was used to detect the concentration of Lp(a), and a polyethylene glycol (PEG)-enhanced immunoturbidimetric assay was used to determine the level of ApoA-Ι and ApoB. A SysmexCA-7000 system (Sysmex, Kobe, Japan) was used to detect the red blood cell (RBC) count, haematocrit (HCT) as well as haemoglobin (Hb) concentration. We used the CKD-EPI 2009SCr equation to calculate eGFR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!